Solid Biosciences Inc. (SLDB) ROE
- 2026-06-30: ROE -55.36%.
- 2026-03-31: ROE -51.26%.
- 2025-12-31: ROE -96.84%.
- 2025-09-30: ROE -76.69%.
Complete source-backed roe history.
- Available history
- 2016-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | -55.36% |
|---|
| 2026-03-31 | -51.26% |
|---|
| 2025-12-31 | -96.84% |
|---|
| 2025-09-30 | -76.69% |
|---|
| 2025-06-30 | -59.66% |
|---|
| 2025-03-31 | -47.43% |
|---|
| 2024-12-31 | -90.86% |
|---|
| 2024-09-30 | -61.33% |
|---|
| 2024-06-30 | -46.93% |
|---|
| 2024-03-31 | -42.83% |
|---|
| 2023-12-31 | -75.91% |
|---|
| 2023-09-30 | -62.92% |
|---|
| 2023-06-30 | -55.13% |
|---|
| 2023-03-31 | -49.36% |
|---|
| 2022-12-31 | -40.62% |
|---|
| 2022-09-30 | -62.43% |
|---|
| 2022-06-30 | -53.63% |
|---|
| 2022-03-31 | -43.46% |
|---|
| 2021-12-31 | -34.67% |
|---|
| 2021-09-30 | -33.55% |
|---|
| 2021-06-30 | -32.87% |
|---|
| 2021-03-31 | -31.03% |
|---|
| 2020-12-31 | -66.84% |
|---|
| 2020-09-30 | -444.37% |
|---|
| 2020-06-30 | -262.32% |
|---|
| 2020-03-31 | -202.52% |
|---|
| 2019-12-31 | -146.44% |
|---|
| 2019-09-30 | -98.86% |
|---|
| 2019-06-30 | -126.87% |
|---|
| 2019-03-31 | -89.30% |
|---|
| 2018-12-31 | -59.75% |
|---|
| 2018-09-30 | -46.43% |
|---|
| 2018-06-30 | -38.11% |
|---|
| 2018-03-31 | -30.84% |
|---|
| 2017-12-31 | 87.95% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | -96.84% |
|---|
| 2024-12-31 | -90.86% |
|---|
| 2023-12-31 | -75.91% |
|---|
| 2022-12-31 | -40.62% |
|---|
| 2021-12-31 | -34.67% |
|---|
| 2020-12-31 | -66.84% |
|---|
| 2019-12-31 | -146.44% |
|---|
| 2018-12-31 | -59.75% |
|---|
| 2017-12-31 | 87.95% |
|---|
| 2016-12-31 | 56.85% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
|---|
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
|---|
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
|---|